149 related articles for article (PubMed ID: 8996148)
1. Fertility after chemotherapy for testicular germ cell cancers.
Lampe H; Horwich A; Norman A; Nicholls J; Dearnaley DP
J Clin Oncol; 1997 Jan; 15(1):239-45. PubMed ID: 8996148
[TBL] [Abstract][Full Text] [Related]
2. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
Pectasides D; Pectasides M; Farmakis D; Nikolaou M; Koumpou M; Kostopoulou V; Mylonakis N
Eur Urol; 2004 Feb; 45(2):187-93. PubMed ID: 14734005
[TBL] [Abstract][Full Text] [Related]
3. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin.
Stephenson WT; Poirier SM; Rubin L; Einhorn LH
J Clin Oncol; 1995 Sep; 13(9):2278-80. PubMed ID: 7545220
[TBL] [Abstract][Full Text] [Related]
5. Fertility after chemotherapy for testicular germ cell cancer.
Pont J; Albrecht W
Fertil Steril; 1997 Jul; 68(1):1-5. PubMed ID: 9207575
[TBL] [Abstract][Full Text] [Related]
6. Fertility after chemotherapy for testicular cancer.
Drasga RE; Einhorn LH; Williams SD; Patel DN; Stevens EE
J Clin Oncol; 1983 Mar; 1(3):179-83. PubMed ID: 6199473
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies of spermatogenic damage in patients with testicular cancer].
Nambu A; Kumamoto Y; Nitta T; Akagashi K; Itoh N; Tsukamoto T
Nihon Hinyokika Gakkai Zasshi; 1995 Jun; 86(6):1123-31. PubMed ID: 7609354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
9. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
10. Spermatogenesis after unilateral orchiectomy for testicular cancer in patients following surveillance policy.
Jacobsen KD; Theodorsen L; Fossa SD
J Urol; 2001 Jan; 165(1):93-6. PubMed ID: 11125372
[TBL] [Abstract][Full Text] [Related]
11. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA
Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009
[TBL] [Abstract][Full Text] [Related]
12. Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer.
Brabrand S; Fosså SD; Cvancarova M; Axcrona U; Lehne G
J Clin Oncol; 2012 Nov; 30(32):4004-10. PubMed ID: 23071246
[TBL] [Abstract][Full Text] [Related]
13. Testicular sperm extraction in azoospermic patients with gonadal germ cell tumors prior to chemotherapy--a new therapy option.
Schrader M; Muller M; Straub B; Miller K
Asian J Androl; 2002 Mar; 4(1):9-15. PubMed ID: 11907623
[TBL] [Abstract][Full Text] [Related]
14. Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance.
Hansen SW; Berthelsen JG; von der Maase H
J Clin Oncol; 1990 Oct; 8(10):1695-8. PubMed ID: 1698935
[TBL] [Abstract][Full Text] [Related]
15. Efficient carboplatin single therapy in a mouse model of human testicular nonseminomatous germ cell tumor.
Aharinejad S; Fink M; Abri H; Nedwed S; Schlag MG; Macfelda K; Abraham D; Miksovsky A; Höltl E; Höltl W
J Urol; 2002 Jan; 167(1):368-74. PubMed ID: 11743358
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
Horwich A; Dearnaley DP; Nicholls J; Jay G; Mason M; Harland S; Peckham MJ; Hendry WF
J Clin Oncol; 1991 Jan; 9(1):62-9. PubMed ID: 1702147
[TBL] [Abstract][Full Text] [Related]
17. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.
Christian JA; Huddart RA; Norman A; Mason M; Fossa S; Aass N; Nicholl EJ; Dearnaley DP; Horwich A
J Clin Oncol; 2003 Mar; 21(5):871-7. PubMed ID: 12610187
[TBL] [Abstract][Full Text] [Related]
18. The influence of hormonal treatment with beta-human chorionic gonadotropin for cryptorchidism on future fertility in rats.
Yilmaz Ö; Akyol İ; Özyurt M; Ateş F; Soydan H; Malkoç E
J Pediatr Urol; 2015 Apr; 11(2):92.e1-4. PubMed ID: 25819376
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants enhance the recovery of three cycles of bleomycin, etoposide, and cisplatin-induced testicular dysfunction, pituitary-testicular axis, and fertility in rats.
Kilarkaje N; Mousa AM; Al-Bader MM; Khan KM
Fertil Steril; 2013 Oct; 100(4):1151-9. PubMed ID: 23850298
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer.
Fosså SD; Silde J; Theodorsen L; Pettersen EO
Br J Urol; 1994 Sep; 74(3):359-65. PubMed ID: 7953268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
